BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, December 11, 2024
Home
»
Authors
» Kay Torrance
Kay Torrance
Articles
ARTICLES
Waiting To Go Public, Avalon Signs Novartis Collaboration
Sep. 14, 2005
By
Kay Torrance
No Comments
Waiting To Go Public, Avalon Signs Novartis Collaboration
Sep. 14, 2005
By
Kay Torrance
No Comments
Chiron Turns Down Novartis' Buyout Offer At $40 Per Share
Sep. 7, 2005
By
Kay Torrance
No Comments
Chiron Turns Down Novartis' Buyout Offer At $40 Per Share
Sep. 7, 2005
By
Kay Torrance
No Comments
After Stock Bounce, Amylin Raises $152M For Pipeline
Aug. 31, 2005
By
Kay Torrance
No Comments
After Stock Bounce, Amylin Raises $152M For Pipeline
Aug. 31, 2005
By
Kay Torrance
No Comments
